Methylation of tumor suppressor gene RASSF1A and BRCA1 in primary epithelial ovarian cancer

Scientific Research and Essays

Volumn 5, Issue 24, 2010, Pages 3939-3944

  Pan, Yong miao ^a   Wu, Yu zhong ^a   Shi, Yi fu ^a   Zhu, Xue qiong ^b  

^a Zhejiang University School of Medicine   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Methylation; Ovarian neoplasms; Plasma DNA; Promoter; Tumor suppressor gene

Indexed keywords

EID: 79251625023     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY (2000). BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study. Cancer Res., 60(19): 5329-5233.
2. Bremnes RM, Sirera R, Camps C (2005). Circulating tumour-derived DNA and RNA markers in blood: A tool for early detection, diagnostics, and follow-up? Lung Cancer, 49(1): 1-12.
3. Chan KY, Ozçelik H, Cheung AN, Ngan HY, Khoo US (2002). Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res., 62(14): 4151-4156.
4. Chaudhry P, Srinivasan R, Patel FD (2009). Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC). Cancer Invest., 27(8): 877-884.
5. Cho YH, Yazici H, Wu HC, Terry MB, Gonzalez K, Qu M, Dalay N, Santella RM (2010). Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res., 30(7): 2489-2496.
6. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst., 5; 92(7): 564-569.
7. Gao B, Xie XJ, Huang C, Shames DS, Chen TT, Lewis CM, Bian A, Zhang B, Olopade OI, Garber JE, Euhus DM, Tomlinson GE, Minna JD (2008). RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res., 68(1): 22-25.
8. Geisler JP, Hatterman-Zogg MA, Rathe JA, Buller RE (2002). Frequency of BRCA1 dysfunction in ovarian cancer. J. Natl. Cancer Inst., 94(1): 61-67.
9. Herman JG (2004). Circulating methylated DNA. Ann. N. Y. Acad. Sci., 1022: 33-39.
10. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. PNAS, 93(18): 9821-9826.
11. Ibanez de Caceres I, Battagli C, Esteller M, Herman JG, Dulaimi E, Edelson MI, Bergman C, Ehya H, Eisenberg BL, Cairns P (2004). Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res., 64(18): 6476-6481.
12. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El- Naggar AK (2008). Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin. Cancer Res., 14(9): 2664-2672.
13. Pfeifer GP, Dammann R (2005). Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Moscow), 70(5): 576-583.
14. Taback B, Hoon DS (2004). Circulating nucleic acids in plasma and serum: past, present and future. Curr. Opin. Mol. Ther., 6(3): 273-278.
15. Teodoridis JM, Hall J, Marsh S, Kannall HD, Smyth C, Curto J, Siddiqui N, Gabra H, McLeod HL, Strathdee G, Brown R (2005). CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res., 65(19): 8961-8967.
16. Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, Boiteux JP, Fontana L, Bignon YJ, Guy L, Bernard-Gallon DJ (2010). Soy Phytoestrogens Modify DNA Methylation of GSTP1, RASSF1A, EPH2 and BRCA1 Promoter in Prostate Cancer Cells. In vivo, 24(4): 393-400.
17. Wong N, Li L, Tsang K, Lai PB, To KF, Johnson PJ (2002). Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma. J. Hepatol., 37(5): 633-639.
18. Yang HJ, Liu VW, Wang Y, Tsang PC, Ngan HY (2006). Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer, 23(6): 212.